ArticleCancers2024

Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies.

Felicitas Schulz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.